Citations

Showing 10 of 108104 citations.

FDA-Cleared versus Laboratory-Developed Tests: Why Start from Scratch When Kits Are Available?
Snozek, Christine L.H.

Mayo Clinic

The Journal of Applied Laboratory Medicine | July 23, 2018 | Volume: 2 | Issue: 1 | Pages: 130-131

10.1373/jalm.2016.021832 | PMID 33636963 Get It

Standardization of Minimal Residual Disease Testing in Multiple Myeloma
Baughn, Linda B. , Linden, Michael A.

Mayo Clinic

The Journal of Applied Laboratory Medicine | July 23, 2018 | Volume: 2 | Issue: 1 | Pages: 118-122

10.1373/jalm.2016.020883 | PMID 33636956 Get It

Antinuclear Antibody Screening: A Delicate Balance for Clinical Laboratories
Cotten, Steven W. , Snyder, Melissa R.

Mayo Clinic

The Journal of Applied Laboratory Medicine | July 23, 2018 | Volume: 1 | Issue: 6 | Pages: 609-612

10.1373/jalm.2017.023374 | PMID 33379812 Get It

Laboratory Utilization and Analytical Validation of Fecal Electrolyte Tests
Parakh, Rugvedita , Greene, Dina N. , Block, Darci R , Ranjitkar, Pratistha , Greene, Dina , Mathias, Patrick C

Mayo Clinic

The Journal of Applied Laboratory Medicine | July 23, 2018 | Volume: 1 | Issue: 6 | Pages: 668-677

10.1373/jalm.2016.022590 | PMID 33379818 Get It

Abstract Background Chronic diarrhea can be categorized as fatty, watery, or inflammatory. Watery diarrhea is further divided into secretory or osmotic types and can be differentiated by measuring fecal electrolytes and osmotic gap. However, with widespread use of endoscopy, it is unclear if these measurements are being used clinically. Furthermore, because stool is not a validated specimen type for Food and Drug Administration–approved electrolyte assays, utilization is a practical concern for laboratories before analytical validation. Here, we determined the clinical utility and validated the performance characteristics of stool electrolytes on the Beckman Coulter AU680. Methods Historical results and literature review were used to determine the clinically relevant ranges for stool electrolytes (Na+, Cl−, K+, phosphate, and Mg2+). Additionally, medical chart review was performed (n = 44 patients) on results to evaluate their clinical utility in chronic diarrhea work-up. Linearity, precision, and stability studies were performed on the AU680. Accuracy was evaluated by comparing results to the Roche Cobas 6000 c501. Results For all cases, stool electrolytes and osmotic gap proved valuable in chronic diarrhea work-up. The imprecision of the assays ranged from 0% to 5.9%. All assays were found to be linear within the instrument's analytical measurement range with appropriate slopes and intercepts. The bias between the AU680 and the Roche c501 ranged from −0.48 to 2.39 (mmol/L or mg/dL). Na+, Cl−, and K+ were stable refrigerated for 5 days and up to 1 freeze-thaw cycle. Phosphate and Mg2+ were stable refrigerated for 48 h, but unstable to freeze-thaw cycles. Conclusions Stool osmotic gap is valuable for evaluating chronic diarrhea and can be calculated using electrolyte concentrations measured on the AU680.
Working With Your Practice to Ensure Appropriate Point-of-Care Usage
Karon, Brad S. , Donato, Leslie J.

Mayo Clinic

The Journal of Applied Laboratory Medicine | July 23, 2018 | Volume: 1 | Issue: 5 | Pages: 603-604

10.1373/jalm.2016.021774 | PMID 33379804 Get It

Spotlight on Laboratory Medicine: A Call for Reflections
Meeusen, Jeffrey W.

Mayo Clinic

The Journal of Applied Laboratory Medicine | July 23, 2018 | Volume: 1 | Issue: 4 | Pages: 462-463

10.1373/jalm.2016.022087 | PMID 33636813 Get It

The Importance of Effective Communication: Some Food for Thought
Baumann, N, Baumann, Nikola A

Mayo Clinic

The Journal of Applied Laboratory Medicine | July 23, 2018 | Volume: 1 | Issue: 4 | Pages: 460-461

10.1373/jalm.2016.021865 | PMID 33636815 Get It

Pediatric Phlebotomy Services: Optimizing Sample Quality and Improving the Patient and Parent Experience
Block, Darci R , Rickard, Twyla M, Johnson, Sharon R., Griesmann, Laurie D, Kang, Nicole S.

Mayo Clinic

The Journal of Applied Laboratory Medicine | July 23, 2018 | Volume: 1 | Issue: 4 | Pages: 453-456

10.1373/jalm.2016.021790 | PMID 33636812 Get It

Identification of Friend or Foe: The Laboratory Challenge of Differentiating M-Proteins from Monoclonal Antibody Therapies
Mills, John R. , Murray, David , Murray, David L.

Mayo Clinic

The Journal of Applied Laboratory Medicine | July 23, 2018 | Volume: 1 | Issue: 4 | Pages: 421-431

10.1373/jalm.2016.020784 | PMID 33636806 Get It

AbstractBackgroundSince the first monoclonal antibody (mAb) therapy hit the market in 1996, the number of disorders treated with this class of therapeutics has seen tremendous growth, with over 50 antibody-based therapeutics currently approved for use in the US and Europe. This class of therapeutics recently made profound progress in the treatment of refractory multiple myeloma (MM). Treating MM with the mAbs will challenge the laboratory's ability to differentiate exogenous mAbs being used to treat patients from endogenous mAbs associated with disease.ContentAn overview of the therapeutic mAbs (t-mAbs) developed for the treatment of MM is provided. The anticipated impact of these therapies on patient care, laboratory testing, and clinical research is discussed. Efforts underway to develop strategies and technologies to help laboratories address the growing challenge of mAb interferences are reviewed.SummaryLaboratories can implement risk mitigation strategies at the preanalytical and postanalytical phase of testing to reduce the likelihood of reporting false-positive M-protein results in patients receiving t-mAbs. However, at the analytical phase of testing, current laboratory methods are ill-suited to differentiate between residual disease and residual drugs. Mass spectrometry–based methods might be best positioned to aid laboratories with the rapidly evolving landscape of MM treatment.
In Reply to Geoffrey Baird on: Utility of Antinuclear Antibody Screening by Various Methods in a Clinical Laboratory Patient Cohort
Crowson, Cynthia S. , Moder, Kevin G., Snyder, Melissa R.

Mayo Clinic

The Journal of Applied Laboratory Medicine | July 23, 2018 | Volume: 1 | Issue: 3 | Pages: 320-321

10.1373/jalm.2016.021600 | PMID 33626848 Get It